BCL2 and leukemia: Within 13 days, the recipient mice treated with vehicle control rapidly succumbed to leukemia irrespective of whether they were transplanted with p185+ B-ALL cells re-programmed with human BCL-2 or human MCL-1 (Figure 4C).